Newsroom

DUBLIN--(BUSINESS WIRE)--The "Down Syndrome Market - A Global and Regional Analysis: Focus on Type, Diagnosis & Treatment Type, and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. While there is no cure, the market encompasses diagnostic tools, early intervention programs, educational therapies, assistive devices, and research into potential pharmacological treatments for associated conditions such as alzheimer's disease, heart defects,...

DISTRIBUTED-WORK-MODEL/OAKLAND, Calif.--(BUSINESS WIRE)--Block, Inc. (“Block”) (NYSE: XYZ) today announced its intention to offer, subject to market conditions and other factors, $1.5 billion aggregate principal amount of senior notes in two series (the “Notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Act”), and outside the United States to non-U.S. persons pursuant to Reg...

ORLANDO, Fla.--(BUSINESS WIRE)--OneRail, a leading provider of last mile fulfillment solutions, today announced a series of strategic leadership appointments designed to strengthen its go-to-market execution, accelerate product innovation and support global expansion. The moves follow OneRail’s $42 million Series C financing round in November 2024, as the company continues to build depth across its leadership bench, adding notable industry experience from top supply chain and logistics technolo...

DUBLIN--(BUSINESS WIRE)--The "Cancer Pain Market - A Global and Regional Analysis: Focus on Drug Class, Distribution Channel, and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The global cancer pain market is undergoing dynamic evolution, fuelled by the rising prevalence of cancer cases globally and the increasing demand for effective pain management therapies. Cancer pain, resulting from tumor growth, treatment interventions, or cancer-i...

DUBLIN--(BUSINESS WIRE)--The "Calcinosis Cutis Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The global Calcinosis Cutis market is highly competitive, with several key players driving innovation and market growth. Companies such as Amgen Inc., MediGene Inc., UCB Pharma, Pfizer Inc., AbbVie Inc., Mundipharma, Vertex Pharmaceuticals, and Medtronic are leading the way in developing treatments for calcinosis cu...

DARMSTADT, Alemania--(BUSINESS WIRE)--Con un público internacional que seguía con expectación los eventos de lanzamiento y en línea, Metop Second Generation A1 (Metop-SGA1), que también alberga la misión Copernicus Sentinel-5 de la Unión Europea, despegó en un cohete Ariane-62 desde el puerto espacial europeo en Kourou, Guayana Francesa, a las 02:37 CEST del 13 de agosto. Como primer satélite del programa EUMETSAT Polar System – Second Generation (EPS-SG), el lanzamiento supone un gran avance h...

DENVER--(BUSINESS WIRE)--Lumen Technologies (NYSE: LUMN) today announced it has exceeded 1,000 customers on its Network-as-a-Service (NaaS) platform—a major milestone in the shift toward faster, smarter enterprise connectivity. As businesses embrace AI to transform operations, the demand for agile, scalable connectivity has never been greater. Lumen’s NaaS platform meets this need with instant speed, control, and scalability, helping companies modernize without the complexity of legacy infrastr...

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the second quarter ending June 30, 2025 and provided a business update. “Following a recent Type A meeting with the FDA, and receipt of the meeting minutes, we believe we have aligned on a path forward for the information needed to resubmit the BLA with Fujifilm as our drug substance manufacturer,” said Matt Pa...

SAN FRANCISCO--(BUSINESS WIRE)--Mobile game publisher Avia wins the Bronze Stevie® Award in the Customer Service Team of the Year category....

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the appointment of Raymond Sanchez, M.D., to its Board of Directors, effective August 12, 2025. Dr. Sanchez is a highly accomplished executive with a strong background in medicine and over 20 years of strategic experience in the life sciences industries. “We are del...